IMAX CORP 8-K

What Happened
IMAX Corporation announced on March 30, 2026, that Chief Executive Officer Richard Gelfond is on a temporary medical leave of absence. The company filed a press release (included as Exhibit 99.1 to its Form 8-K) stating that, during his absence, senior executives are handling day-to-day responsibilities in coordination with one another and Darren Throop, Chair of the Board, with regular communication with the full Board of Directors.

Key Details

• Date filed: March 30, 2026 (Form 8-K, Regulation FD disclosure).
• Executive on leave: Richard Gelfond, Chief Executive Officer.
• Interim operations: Senior executives and Chair Darren Throop are coordinating daily management duties.
• Disclosure: Press release attached as Exhibit 99.1 to the 8-K.

Why It Matters
This is a leadership continuity disclosure — IMAX confirms management and the board are actively managing operations while the CEO is temporarily absent. For investors, the key items to watch are any future filings or updates on the expected duration of the leave, any interim executive appointments, and any material operational or financial impacts that could result from an extended absence.